arginyl-glycyl-aspartic acid has been researched along with Leukemia L 1210 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Mejia, EG; Dia, VP; Wang, W | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Leukemia L 1210
| Article | Year |
|---|---|
Lunasin, with an arginine-glycine-aspartic acid motif, causes apoptosis to L1210 leukemia cells by activation of caspase-3.
Topics: Amino Acid Motifs; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Stability; Enzyme Activation; G2 Phase; Hydrolases; Inhibitory Concentration 50; Leukemia L1210; Mice; Oligopeptides; Phytotherapy; Plant Extracts; Soybean Proteins; Time Factors | 2010 |